Abstract: The rural and marginal people of Bangladesh are deprived of modern treatment facilities and hence greatly depend on medicinal plants. Besides, the higher cost and toxicity of synthetic drugs drives scientists towards search for natural source of medication for a number of diseases. Cost-effectiveness, easy availability and fewer side effects are making the herbal medicine more popular both among rural and city people. Plants with Cytotoxic and clot lysis potential are good candidate as source of novel anti-tumor agents and thrombolytic drugs. This study aimed at screening out of phytochemical constituents and evaluation of cytotoxicity and thrombolytic potential of an important medicinal plant Achyranthes aspera methanolic leaf extract. In vitro phytochemical screening of A. aspera leaf extract carried out by qualitative tests revealed the presence of alkaloids, glycosides, cardiac glycosides, flavonoids, tannins, terpenoids, steroids and saponins while phlobatannins were absent. Cytotoxicity test of A. aspera leaf extract carried out by Brine shrimp Lethality (BSL) Bioassay showed the highest percentage of mortality (90%) in 1250 μg/ml and LC50 value was 50.12 μg/ml. Thrombolytic test showed 32.87 ± 9.42% clot lytic activity for A. aspera while positive control (streptokinase) and negative control (water) showed 81.19 ± 3.78% and 6.67 ± 2.58% clot lysis, respectively. Synergistic effect of streptokinase and A. aspera extract also produced better result (56.30 ± 6.95%) than A. aspera alone.
Keywords: Achyranthes aspera, cytotoxic, thrombolytic, phytochemical screening, LC50
[1]. Cos, P.; Vlietinck, A. J.; Vanden, B. D. and Maes, L.; Anti-infective potential of natural products: How to develop a stronger in vitro "proof-of concept‟. Journal of Ethnopharmacology 106, 2006, 290-302.
[2]. Emori, C.T. and Gaynes, R. Clinical Microbial Review, 6, 1993, 428-442.
[3]. Srivastava, J., Lambert, J. and Vietmeyer, N. J. W.k Technical Paper.No. 1996, 320.
[4]. Uniyal, K.S., Singh, N.K., Jamwal, P. and Lal, B. 2006. J. Ethnobiol., 2, 1-14.
[5]. de Lange, P.J., Scofield, R.P., Greene, T. Achyranthes aspera (Amaranthaceae), a new indigenous addition to the flora of the Kermadec Islands group. New Zealand J. Bot., 42, 2004, 167-173.
[6]. Akter, A. and Zuberi, M.I. Invasive alien species in Northern Bangladesh: Identification, inventory and impacts, International Journal of Biodiversity and Conservation, 1(5), 2009, 129-134.
[7]. Khan, M.S., Neela, F.A., Aktar, A., Rahman, M.M. and Alam, M.F. Antibacterial activity of Achyranthes aspera L.: An In- vitro study, J. Environ. Sci. Nat. Resour., 2, 2009, 45-48.
[8]. Saravanan, P., Ramasamy, V. and Shivakumar, T. Antimicrobial activity of leaf extracts of Achyranthes aspera Linn., Asian Journal of Chemistry, 20(1), 2008, 823-825.
[9]. Chakraborty, A., Brantner, A., Mukuinaka, T., Nobukuni, Y., Kuchido, M. and Konoshima, T. Cancer chemo preventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two stage mouse skin carcinogenesis. Cancer Letters, 177(1), 2002, 1–5.
[10]. Bafna, R.A. and Mishra, H.S. Ars Pharmaceutica, 45(4), 2004, 343-351.